Novartis at TPD Summit 2026
Oct 26–29, 2026 Boston, MA ~300 attendees Website
Novartis takes part in 2 sessions at TPD Summit 2026 in Boston. Its sessions cover modelling targeted protein degradation from cell experiments through to the clinic, and how investment in induced proximity is shaping development.
| Organization | TPD Summit 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company developing and marketing medicines in oncology, immunology, cardiovascular disease and neuroscience. | Talk Tue Oct 27 5:00pm Modelling Targeted Protein Degradation from Cells to the Clinic AI & computational design Panel Wed Oct 28 10:00am Shaping Investment in Induced Proximity: Insights to Accelerate Development & Secure Funding Investment, partnering & strategy |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction